The Latest Cardiac and Vascular News
Sovateltide is an endothelin B receptor agonist that increases blood flow, shows anti-apoptotic activity, protects neural mitochondria, and produces neurovascular remodeling WILLOWBROOK, Ill., Feb. 17, 2022 (GLOBE NEWSWIRE) — Pharmazz, Inc. (“Pharmazz”), a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in critical care, announced today […]
Daxor’s BVA-100® Shown to Provide Unique and Actionable Data for Addressing Heart Failure Oak Ridge, TN, Feb. 17, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the importance and clinical utility of Daxor’s BVA-100 blood test in heart failure (HF) patients […]
REVERSE-HF will evaluate rehospitalizations and survival when using the Aquadex therapy MINNEAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) today announced the company will evaluate the clinical outcomes and economic value of its Aquadex® therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening […]
Rosemont, Ill., Feb. 16, 2022 (GLOBE NEWSWIRE) — The Society for Vascular Surgery and the Enhanced Recovery after Surgery (ERAS®) Society have released a consensus statement intended to help address perioperative challenges faced by vascular surgery patients. The ERAS® pathways have been beneficial for many surgical specialties, and the application […]
Press release Malmö, Sweden, February 17, 2022 Correction of press release: Acarix AB (publ) publishes Year-End Report 2021 The press release published today at 08.00 CET did not include the quarterly report. The quarterly report is included in the press release below, which otherwise correspond to the previously published press release. For more information contact: Christian […]
These authorizations enable the simultaneous launch of recruitment for these international studies, which should be completed in the first half of 2023. The INSIGHT and INSIGHT 2 randomized, placebo-controlled studies are designed to include a total of 800 volunteers with mild to moderate elevated blood pressure, with 400 volunteers in […]
Findings from Cleerly’s groundbreaking CLARIFY 2 study echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease evaluation. The study, the second of six studies comparing Cleerly analysis against current gold standards to plaque and coronary artery imaging, demonstrates Cleerly’s effectiveness in the identification and exclusion of […]
The new service will allow for frequent follow-ups, immediate medication or treatment adjustment, and more. New York, NY – February 17, 2022 – As the leading telehealth provider making quality healthcare accessible to all Americans, Antidote Health has announced a new core offering to their suite of services that will […]
PLANO, Texas, Feb. 16, 2022 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics™), a national remote monitoring provider and technology leader in deep learning artificial intelligence, has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal […]
MONTREAL and CHARLOTTE, N.C., Feb. 16, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer, effective February 15, 2022. Dr. Bharucha is a cardiac electrophysiologist who brings to Milestone over thirty years of […]
